Skip to main content
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: J Pharmacol Exp Ther. 2006 Nov 14;320(2):774–781. doi: 10.1124/jpet.106.104992

Fig. 7.

Fig. 7

Effects of PKC activator PMA (1 μM) or inhibitor calphostin C (1 μM) on PPAPα expression and effect of PKC inhibition on clofibrate (10 μM)-induced increase in PPARα expression in CMVEC. The blot shown is a representative of three replicate blots, quantified using ImageQuant and expressed as an arbitrary unit. The results are presented as mean ± S.E.M. (*, compared with control; #, compared with calphostin C and clofibrate; p < 0.05, n = 5, ANOVA).